MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$16,178K
(88.45%↑ Y/Y)
Net loss
-$16,141K
(88.47%↑ Y/Y)
Total other
comprehensive income (loss)
-$37K
(-236.36%↓ Y/Y)
Foreign currency
translation adjustment
$169K
(173.48%↑ Y/Y)
Loss before income
taxes
-$14,970K
(89.26%↑ Y/Y)
Provision for income taxes
$1,171K
(80.99%↑ Y/Y)
Unrealized gain on
marketable securities
-$206K
(-194.06%↓ Y/Y)
Interest income
$8,897K
Other income
(expense), net
$443K
(-97.26%↓ Y/Y)
Product revenue, net
$372,072K
(123.41%↑ Y/Y)
Other revenue
$4,000K
(-86.67%↓ Y/Y)
Loss from operations
-$12,227K
(90.48%↑ Y/Y)
Interest expense
$12,083K
(-55.52%↓ Y/Y)
Total revenues
$376,072K
(91.34%↑ Y/Y)
Total operating
expenses
$388,299K
(19.50%↑ Y/Y)
Selling, general and
administrative
$274,553K
(19.69%↑ Y/Y)
Research and development
$77,051K
(0.83%↑ Y/Y)
Cost of sales
$36,695K
(91.84%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)